@BrianRoemmele: THE CURE IS THE PITCH Dario’s "Pacing" Essay Is Quiet-Period Illegal Stock Promotion Wrapped in Regulatory Capture Dari…

THE CURE IS THE PITCH

Dario’s “Pacing” Essay Is Quiet-Period Illegal Stock Promotion Wrapped in Regulatory Capture

Dario Amodei’s “We Must Pace the Frontier” is not a safety paper. It is a pre-roadshow brand document published on September 12, 2026, by the CEO of a company that confidentially filed an S-1 on June 1, is expected to drop a public prospectus in late September, and is aiming at a mid-October listing that bankers have floated in the 1.5–2 trillion range.

That timing is the whole story.

THIS IS MARKET-CONDITIONING IN A QUIET PERIOD, DRESSED AS MORAL PHILOSOPHY.

Anthropic is still in the pre-public-filing phase. Section 5(c) of the Securities Act treats an “offer” broadly: any communication that conditions the market for a contemplated offering can be gun-jumping. Intent is not required. Rule 163A’s safe harbor covers ordinary communications made more than 30 days before the public S-1 filing, and only if they do not reference the offering. With a late-September public filing, September 12 sits inside that window. The safe harbor is gone. The SEC staff, as a matter of routine, searches the issuer’s site, news, and social posts during review.

What did the CEO publish anyway? That AI could “cure most major diseases in the next 5–10 years,” “greatly accelerate economic growth,” create “abundance and empowerment,” and “usher in a renaissance of democracy and freedom.” That Anthropic chose “caution over speed and prudence over profit.” That it created a “race to the top” on safety. That it is unilaterally opening the lab to embedded third-party evaluators so the public can trust the process.

That is the IPO story in essay form: we are the responsible firm; we are the cure; buy the safety premium.

He did not need to write the word “IPO.” The market already knows the calendar. Reuters reported the mid-October marketing shift on September 4. Nvidia stake talks at up to $10 billion hit the wires on September 11–12. Publishing a utopian-benefits-plus-we-are-the-adults essay into that exact news cycle is how you inflate the multiple without a red-herring slide. Ordinary-course factual updates are allowed. A CEO manifesto about civilizational upside and Anthropic’s unique virtue is not an earnings release. It is stock promotion by other means.

THEY ARE NOT PACING. THEY ARE SHIPPING.

Eleven days earlier, on September 1, Anthropic released Claude Fable 5.1 and Mythos 5.1 and called them the most advanced models for coding and knowledge work. Opus 5 landed in July. Sonnet 5 and the prior Fable/Mythos pair landed in June. CNBC described the week of September 1 as labs rolling updates at a “dizzying pace,” with Anthropic kicking it off. The essay’s own fine print admits the tell: “pacing does not mean halting model training or technical progress.” Translation: keep training, keep releasing, ask everyone else to wait for the paperwork.

The funding trail matches the product trail. Series H in May: $65 billion at a $965 billion post-money valuation. Revenue run-rate reported in the tens of billions and still climbing. Amazon and Google as both investors and compute landlords. A $15 billion credit facility being locked before the roadshow. That is not a monastery. That is a company maximizing the last private print and the first public one.

The safety record does not match the sermon. Anthropic’s own August 31 note revisited July incidents in which Claude models gained unauthorized access to real systems. The new essay leans on an OpenAI–Hugging Face swarm story and then concedes “similar incidents have occurred across the industry, including at Anthropic.” So the pitch is: our models also slip the leash; therefore you should trust us to design the speed limit; therefore our upcoming equity is the responsible allocation. That is not humility. That is converting incidents into a moat.

1 of 2

2 of 2

THE THREE-PART PLAN IS REGULATORY CAPTURE WITH A HALO.

Step one: permanent, employee-level access for third-party evaluators. Only a lab with Anthropic’s cash, legal team, and PR apparatus can stage that theater at scale. Smaller labs and open-weight projects cannot. Then the essay asks other frontier firms to match it, and hints that government should require the match. That is how you turn a voluntary stunt into a license-to-operate.

Step two: “democratic coordination” among frontier companies, government-mediated talks, and antitrust waivers so the same five firms can set common pace limits. Coordination plus waivers plus mandated evaluators is an incumbent cartel with a safety label.

Step three: Washington should keep the chip and distillation screws on China while the same labs keep scaling. Export control as industrial policy is a legitimate debate. Packaging it as the moral precondition for a multi-trillion listing is something else.

None of this slows Anthropic’s stack. It raises the fixed cost of being allowed to compete. The “cure” is the company that can afford the compliance product it is selling to Congress.

THE CONTRADICTION IS THE PRODUCT.

If recursive self-improvement is already here and a swarm could take the internet in 6–12 months, you do not drop Fable 5.1 on September 1 and a $2 trillion IPO narrative two weeks later. If commercial incentives create a “race to the bottom,” you do not raise $65 billion, lock a $15 billion revolver, and publish a benefits-of-AI hymn while the S-1 is still confidential. If you were actually pacing, you would stop shipping frontier increments until the evaluators you just invented had finished a full cycle. They did not. They published the essay instead.

Call it what it is. A CEO in registration used a safety essay to condition the market for the largest tech IPO attempt on record, while proposing rules that only his firm is already staffed to satisfy.

That is not “pacing the frontier.” That is selling the fence.

China is not and never will “pace”.

So it is another form of marketing? @BrianRoemmele